NCPA files lawsuit to stop pharmacy DIR fees
NCPA fights against DIR fees. Help the fight against these fees!
Compounded Hormone Therapy At Risk
Given the FDA’s demonstrated hostility towards compounded bioidentical hormones, it’s been our contention that the agency wants to ban BHRT to protect the profits of Big Pharma. In its [...]
FDA’s Role in Pharmacy Compounding
IACP cheers reintroduction of legislation to clarify FDA role in pharmacy compounding- The International Academy of Compounding Pharmacists today cheered the reintroduction of The Preserving [...]
Why Oxytocin Is a Helpful Hormone
Oxytocin has classically been regarded as a pregnancy and lactation hormone. It’s also infamous as the “cuddle chemical” since it is released during orgasm and tends to bind couples together [...]
Compounding Update: HCG (Human chorionic gonadatropin)
The FDA has provided a preliminary list of products that were originally approved as drug products, but that will be considered biologic products as of March 23, 2020.1 Human chorionic [...]
